JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayes, A
Right arrow Articles by Mann, D M A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayes, A
Right arrow Articles by Mann, D M A
Related Collections
Right arrow Neuropathology
Right arrow Other immunology
Right arrow Genetics
Right arrow Dementia
Journal of Neurology Neurosurgery and Psychiatry 2004;75:1475-1477
© 2004 BMJ Publishing Group Ltd


SHORT REPORT

A polymorphic variation in the interleukin 1A gene increases brain microglial cell activity in Alzheimer’s disease

A Hayes1, E K Green2, A Pritchard2, J M Harris2, Y Zhang2, J C Lambert3, M C Chartier-Harlin3, S M Pickering-Brown4, C L Lendon2, D M A Mann1

1 Neuroscience Research Group, University of Manchester, Greater Manchester Neurosciences Centre, Hope Hospital, Manchester M6 8HD, UK
2 Molecular Psychiatry Department, Division of Neuroscience, Queen Elizabeth Psychiatry Hospital, University of Birmingham, Birmingham B15 2QZ, UK
3 INSERM 508, Institut Pasteur de Lille, 59019 Lille Cedex, France
4 Department of Old Age Psychiatry, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, UK

Correspondence to:
Correspondence to:
Professor D M A Mann
Neuroscience Research Group, University of Manchester, Greater Manchester Neurosciences Centre, Hope Hospital, Salford M6 8HD, UK; david.mann{at}man.ac.uk


ABSTRACT
Objective: To investigate the impact of possession of the –889 C/T polymorphism of the interleukin 1A gene (IL-1A) and the –511 C/T polymorphism of the interleukin 1B gene (IL-1B) on the extent of neuroinflammation in the brain in Alzheimer’s disease (AD), as demonstrated by the degree of microglial cell activity associated with each IL-1A and IL-1B genotype.

Method: Microglial cell activity within the frontal cortex was determined in 68 patients with necropsy confirmed AD by image analysis as the percentage area of tissue occupied by ferritin immunostained material (microglial cell load). IL-1A, IL-1B, and apolipoprotein E (APOE) genotyping were performed by polymerase chain reaction on DNA extracted from frontal cortex or cerebellum.

Results: The microglial cell load was 31% greater in patients with IL-1A T allele, 62% greater with IL-1A TT genotype, but 108% greater with IL-1A TT genotype in combination with APOE {varepsilon}4 allele. No effects on microglial cell load occurred with polymorphisms in IL-1B, or APOE alone.

Conclusions: Polymorphisms within IL-1A influence the degree of brain microglial cell activation, especially in bearers of APOE {varepsilon}4 allele, reinforcing the importance of neuroinflammatory processes in the pathogenesis of AD, and supporting the rationale for treating the disease with inflammation modulating drugs.


Abbreviations: Aß, amyloid ß; AD, Alzheimer’s disease; APOE, apolipoprotein E; IL, interleukin

Keywords: Alzheimer’s disease; interleukin 1; microglial cells; neuroinflammation







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 by the BMJ Publishing Group Ltd.